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Abstract
A remarkable feature of regenerative processes is their ability to halt proliferation once an organ’s
structure has been restored. The Wnt signaling pathway is the major driving force for homeostatic
self-renewal and regeneration in the mammalian intestine. The mechanisms that counterbalance
Wnt-driven proliferation are poorly understood. We demonstrate here that YAP, a protein known
for its powerful growth-inducing and oncogenic properties1-2, has an unexpected growth-
suppressive function restricting Wnt signals during intestinal regeneration. Transgenic expression
of YAP reduces Wnt target gene expression and results in the rapid loss of intestinal crypts. In
addition, loss of YAP results in Wnt hypersensitivity during regeneration, leading to hyperplasia,
expansion of intestinal stem cells (ISCs) and niche cells, and formation of ectopic crypts and
microadenomas. We find that cytoplasmic YAP restricts elevated Wnt signaling independently of
the APC/Axin/GSK3β complex partly by limiting the activity of Dishevelled (DVL). DVL signals
in the nucleus of ISCs and its forced expression leads to enhanced Wnt signaling in crypts. YAP
dampens Wnt signals by restricting DVL nuclear translocation during regenerative growth.
Finally, we provide evidence that YAP is silenced in a subset of highly aggressive and
undifferentiated human colorectal carcinomas (CRC) and its expression can restrict the growth of
CRC xenografts. Collectively, our work describes a novel mechanistic paradigm for how
proliferative signals are counterbalanced in regenerating tissues. Additionally, our findings have
important implications for the targeting of YAP in human malignancies.
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YAP is a critical component of the size-controlling Hippo signaling pathway1-2. Through a
kinase cascade, the pathway targets YAP for phosphorylation, preventing its nuclear
translocation where it functions as a transcriptional co-activator. Current dogma suggests
that restriction of YAP s transcriptional activity is the principal mechanism of growth and
tumor suppression by the Hippo pathway2. Indeed, nuclear YAP is a powerful driver of
organ growth, progenitor proliferation, and tumor growth1-4. We previously assessed YAP
function in the mammalian intestine by utilizing a mouse model that resulted in ubiquitous
postnatal expression of an inducible YAP-S127A mutant3. This mutant protein is thought to
have enhanced nuclear localization given that it escapes inactivation by the Hippo kinases
LATS1/23. As YAP might activate paracrine signals5, we sought to bypass non cell-
autonomous effects by specifically expressing YAP in the intestinal epithelium using the
Villin-rtTA driver 6. YAP protein in Tg intestine was not restricted to the nucleus,
suggesting that S127 is not the major determinant of YAP sub-cellular localization in this
tissue (Supplementary Fig 1a). 5-7 days following Dox administration, Tg mice became
moribund and were euthanized. Surprisingly, histological evaluation of the small intestine
and colon of Tg mice revealed a progressive degenerative phenotype associated with the
rapid loss of proliferating crypts (Fig. 1a, Supplementary Fig. 1b, c).
Crypt loss phenotypes are typically associated with reduced Wnt signaling7. Indeed,
degeneration was accompanied by repression of the Wnt target gene CD44 and loss of cells
displaying nuclear β-catenin (Fig. 1b, e and Supplementary Fig. 1e-g). Paneth cells are a
mature intestinal lineage that require high levels of Wnt signaling for their proper
differentiation and localization, and function as a critical component of the ISC niche 8-9. In
YAP Tg mice, Paneth cells become mislocalized and eventually disappear (Supplementary
Fig. 1d). To determine if YAP expression was reducing ISC numbers, we performed in situ
hybridization (ISH) for Olfm4, which marks crypt base columnar (CBCs) stem cells 10.
Olfm4+ CBCs were drastically reduced 2 days post induction and were essentially absent by
day 4 (Fig. 1c). Consistent with these data, microarray analysis on isolated crypts showed
that many of the top downregulated transcripts were known ISC signature genes (i.e.-Olfm4,
Ascl2, Smoc2 and Lgr5) (Fig. 1d and Supplementary Fig. 2a, b). Gene set enrichment
analysis (GSEA) demonstrated significant downregulation of both intestinal β-catenin
targets and a recently described ISC gene signature11,12 (Supplementary Fig. 1c and
Supplementary Table 1). Inhibition of growth, loss of Paneth cells and suppression of Wnt/
ISC signature genes were confirmed in organoid cultures derived from Tg mice
(Supplementary Fig. 1d, e)9. Together, these results demonstrate that in contrast to other
tissues where it promotes growth, epithelial-specific expression of YAP suppresses intestinal
renewal, which occurs through inhibition of the Wnt-signaling pathway.
These observations prompted us to evaluate more carefully the phenotype of gut-specific
YAP mutant mice. Consistent with a previous report13, developmental or acute YAP loss
produced no major abnormalities during normal intestinal homeostasis (Fig. 2b and
Supplementary Fig. 3a). However, following injury by whole-body irradiation (9 & 11gy),
Vill-Cre Yap f/f (cKO) mice displayed a striking phenotype of crypt hyperplasia and
overgrowth throughout the small intestine and colon (Fig. 2a and Supplementary Fig. 3c, e).
This observation contrasts to that of impaired repair observed in a DSS-mediated colitis
model13 (Supplementary Fig. 3b). cKO crypts were hyperproliferative and displayed
upregulation of the Wnt target genes CD44 and SOX9 as well as mislocalized and increased
numbers of Paneth cells (Fig 2a and Supplementary Fig. 3f). Apoptosis was not altered in
cKO mice (Supplementary Fig. 3d). Considering that intestinal regeneration following
irradiation is characterized by a state of Wnt hyperactivity14-15, our data suggest a role for
YAP in restricting elevated Wnt signaling in vivo.
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To directly test if loss of YAP results in Wnt hypersensitivity, we injected adenovirus
expressing R-Spondin1 (Ad-RSpo1) into cKO and control mice. RSpo1 is a potent secreted
Wnt agonist that induces crypt cell proliferation16-17. Seven days after Ad-RSpo1 injection,
80% of cKO mice (n=8) became moribund and were euthanized, whereas Ad-Fc injected
control mice (n=8) appeared normal. cKO intestines and colon displayed a massively
hyperplastic phenotype so that by day 7, most mature intestinal lineages in cKO epithelia
were replaced by highly proliferative crypt-like tissue (Fig. 2b,c and Supplementary Fig. 4a-
i). Hyperplasia was accompanied by upregulation of Wnt targets CD44, SOX9 and EPHB3,
in addition to global upregulation of the intestinal β-catenin target signature (Fig. 2d-f and
Supplementary Fig. 4j). To determine if YAP loss resulted in expansion of cells with the
features of ISCs, we generated cKO:Lgr5-EGFP mice. LGR5 is normally expressed in the
CBCs at the very bottom of the crypt (Fig. 2g inset), however, following RSpo1
administration in control mice, the population of Lgr5+ ISCs is expanded (Fig. 2g). This
expansion is much more striking in the cKO intestine, where the Lgr5+ domain is 3-4 times
in size. ISC expansion was confirmed by ISH for Olfm4, and GSEA (Supplementary Fig. 5a
and Fig. 2e and Supplementary Table 1). cKO mice also displayed a dramatic increase in
Paneth cell numbers (Fig. 2h and Supplementary Fig. 5b, c and d). Paneth cells and Lgr5+
cells were evident high in the crypt/villus axis (Fig. 2g, Supplementary Fig. 5d). cKO mice
also displayed ectopic epithelial foci resembling crypts formed within villi that stained
positive for CD44, Lys, and proliferative markers (Fig. 2i and Supplementary Fig. 5e-g).
Some of these progressed into structures reminiscent of microadenomas, precancerous
lesions where outpocketing pouches of crypt-like tissue grow into normal villi
(Supplementary Fig. 5g). These were never observed in control RSpo1-treated animals.
Together, these results demonstrate that YAP restricts the expansion of ISCs as well as
critical components of the stem cell niche.
To gain insight into the mechanism behind our observations, we revisited the expression
pattern of YAP in the intestine. It has previously been shown that YAP protein is primarily
localized to the crypt base, and is absent from villi3,13. Using a new polyclonal antibody, we
find that YAP is nuclear enriched in CBCs and lower crypt cells (Supplementary Fig. 6a-c)
but also expressed in upper TA (transit amplifying) cells and throughout the villi, where it is
predominantly cytoplasmic (Supplementary Fig. 6a). This was confirmed by cellular
fractionation experiments (Supplementary Fig. 6d). YAP localization correlated to the
staining pattern of CD44, demonstrating that nuclear YAP is present in zones of active Wnt
signaling, but is mostly cytoplasmic where Wnt is restricted (Supplementary Fig. 6e). These
data suggest that cytoplasmic YAP might be functionally responsible to terminate Wnt
signaling and allow progress from a proliferative progenitor/stem cell compartment to a
postmitotic, differentiated fate. To rule out the possibility that a transcriptional function of
YAP was repressing Wnt, we generated Yapfl/S79A Villin-Cre mice. The YAP protein in
these mutants cannot bind to TEAD transcription factors, the main transcriptional effectors
of YAP 18-19. Following RSpo1 injection, we observed no enhanced Wnt response in YAP
S79A mutant mice (Supplementary Fig. 7a). Supporting a role for cytoplasmic YAP in
restricting Wnt signaling, expression of YAP-WT and a YAP-S127D phospho-mimic
limited Wnt reporter responsiveness in 293T cells (Supplementary Fig. 7b, c).
The phenotype observed in cKO mice treated with RSpo1 histologically resembled acute
Apc deletion (Supplementary Fig. 8)20. Surprisingly, we observed no obvious changes in β-
catenin protein levels in hyperplastic cKO crypts (Supplementary Fig. 8a-c). As increases in
β-catenin protein are the direct consequence of disrupting the AXIN/APC/GSK3β complex,
these data suggest that YAP restriction of Wnt signaling is likely not mediated by
modulating the activity of this complex. It has been recently suggested that phosphorylated
YAP (cytoplasmic) sequesters β-catenin in the cytoplasm in cell lines21. Though we
observed a subtle expansion in the number of nuclear β-catenin positive cells in cKO
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mucosa (Supplementary Fig. 8b), these likely represent the expansion of Paneth cells and we
infer that this does not represent the major mechanism of YAP-mediated Wnt repression. In
vitro, we observed increased Wnt activity after combined YAP and APC depletion versus
APC only knockdown, and a synergistic effect of YAP depletion together with GSK3β
small molecule inhibition (Supplementary Fig. 8d, e). In mice, combined deletion of APC
and YAP (DKO) versus APC only in an acute or a long-term adenoma model22 resulted in a
robust upregulation of CD44 in addition to significant increases in the number of Paneth
cells and proliferative cells (Supplementary Fig. 9a-g). Thus, our data suggest that YAP acts
to restrict Wnt signaling independently, and in some cases synergistically, to the activity of
destruction complex and control of subcellular localization of β-catenin.
Recently, it was reported that TAZ, a protein that bears a 57% homology to YAP, interacts
with Dishevelled (DVL)23, a positive Wnt signaling regulator. Work primarily done in
Drosophila has shown that DVLs act in the cytoplasm upstream of the β-catenindestruction
complex. However, emerging work in mammals suggest that DVL also exists in the nucleus
mediating the Wnt transcriptional response partly in conjunction with c-Jun and TCF4 24-25.
We determined that YAP also interacts with DVL2 (Supplementary Fig. 10a). The function
of DVLs in intestinal regeneration has been poorly characterized, although the observation
that loss of DVL2 causes a decrease in intestine length and crypt diameter suggests an
important role in intestinal biology26. We find that DVL2 expression is restricted to the
crypt compartment, where it is localized in the nucleus of CBCs and assumes a more diffuse
pattern in the TA compartment (Fig. 3a). Furthermore, DVL2 nuclear localization is
enhanced in crypts after RSpo1 administration and during regeneration following irradiation
(Fig. 3b and Supplementary Fig. 10b). To evaluate the role of nuclear DVL in crypts, we
infected organoids with lentiviruses expressing a Dox-inducible DVL carrying a nuclear
localization signal (DVL-NLS)25. DVL-NLS increases Wnt target gene expression and leads
to the transient formation of spheroid organoids resembling those with constitutive Wnt
signaling (Fig. 3e)9. In addition, expression of DVL-NLS after APC knockdown results in a
synergistic activation of the TOPflash Wnt reporter (Supplementary Fig. 10c). Thus, our
findings are consistent with an important nuclear function of DVL in intestinal progenitors
and Wnt signaling in parallel or downstream to the destruction complex.
Given the observed physical interaction between YAP and DVL2 and their overlapping
patterns of sub-cellular localization in crypts, we hypothesized that YAP might control
DVL2 sub-cellular localization and/or activity. We observed a massive expansion of cells
positive for nuclear DVL2 in cKO mice treated with RSpo1 and during radiation-induced
regeneration (Fig. 3b and Supplementary Fig. 10b). Additionally, YAP knockdown led to
DVL nuclear accumulation in DLD1 cells (Fig. 3c and Supplementary Fig. 10d,e). We
found no increase in levels of nuclear β-catenin in this context (Supplementary Fig. 10e).
Loss of DVL2 and DVL3 partially or completely rescued increased Wnt target genes in the
absence of YAP (Fig. 3d). To determine if YAP could block DVL-induced Wnt
transcriptional responses, we generated organoids expressing Dox-inducible DVL-NLS
(Supplementary Fig. 10f) and YAP. Expression of YAP completely abrogated the DVL-
mediated upregulation of the Wnt target genes Lgr5 and Axin2 (Fig. 3e). Therefore, we
conclude that YAP is critical for the proper sub-cellular localization of DVLs and blocks
their ability to induce Wnt signaling.
Lastly, we investigated the role of YAP in human CRC. Using DLD1 cells infected with
Dox inducible YAP-WT or YAP-S127D, we performed xenograft assays to assess the effect
of YAP on tumor growth. We found a dramatic decrease in tumor growth with the addition
of Dox, particularly with YAP-S127D (Fig. 4a and Supplementary Fig. 11a, b). This
decrease in tumor size coincided with global suppression of the CRC TCF4/β-catenin27 and
ISC11 gene signatures (Fig. 4b, c, Supplementary Fig. 11c, d and Supplementary Table 1).
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We next examined if YAP loss was associated with human CRC by evaluating YAP
expression in a cohort of 672 CRC samples using immunohistochemistry28. Complete loss
of YAP staining occurred within a minor subset of human tumors (10.5%), but predicted
worse patient survival and was associated with high grade, stage IV disease, compared to
YAP positive groups (Supplementary Fig. 11e-h and Fig. 4d-f). These results are consistent
with our animal data and demonstrate that YAP may act as a tumor suppressor in human
CRC.
Precise mechanisms must exist to dampen proliferative potential to maintain organ size.
Here, we have identified YAP and DVLs as key players in this process by restricting the
expansion of ISCs and their niche during Wnt-driven regeneration. Although we have not
ruled out a pro-proliferative role for nuclear YAP, our results suggest that the predominant
function of YAP in the intestine is growth-restrictive. During normal development and
homeostasis, TAZ (whose expression is highly enriched in crypts - Supplementary Fig. 6d)
might be compensating for the loss of YAP. Alternatively, YAP together with DVL might
be part of a regeneration-exclusive molecular machinery that helps counteract hyperactive
Wnt signaling, which occurs during emergency growth. Interestingly, YAP is a WNT target
gene29, suggesting that it might participate in a negative feedback loop to limit WNT-
initiated signals. Current therapeutic efforts are aimed at diminishing YAP protein levels in
many malignancies, including CRC30. Our results suggest that such manipulations could
potentially result in increased tumor growth. YAP targeting therapies should aim to disrupt
the YAP/TEAD interaction or induce the cytoplasmic translocation of YAP. Further study of
the role of YAP as a growth suppressor is likely to provide important insight into the
biology of regeneration, size control, and tumor progression.
METHODS
Mice
Yap1 conditional knockout and S79A point mutant mice were previously described 19. Yap1
cKO mice were intercrossed with Villin-Cre31 , Villin-CreER 32, Lgr5-EGFP-IRES-
CreER 33, and Apc fl/fl mice 34. Mice were given a single dose of tamoxifen (1mg in corn
oil injected i.p.) in Yap/Apc conditional knockout experiments with Villin-CreER. Villin-
rtTA mice were described previously 6.
For in vivo administration of R-Spondin1, adenovirus expressing Fc-tagged R-Spondin1 of
mouse origin was retro-orbitally injected at 3×108 PFU. Virus was produced as previously
described 16. Tissue was collected at 3.5 or 7 days. For irradiation experiments, mice were
exposed to 9 or 11Gy at a dose of 0.664Gy/minute from Cesium 137-irradiator. Tissue was
collected 5 days after irradiation.
Immunohistochemistry of mouse tissue
Staining was performed with the following antibodies using the Vectastain ABC-Elite kit
according to manufacturers instructions, with the exception of Cryptdin1, which was
detected using an anti-goat Alexa-Fluor 488 (Invitrogen): rabbit anti-YAP (Cell Signaling
1:40, Avruch Lab 1:400), mouse anti-PCNA (Santa Cruz Biotechnology), rat anti-CD44
(BD Biosciences 1:100), rat anti-Ki67 (Dako 1:40), rabbit anti-phospho histone H3
(Millipore 1:300), rabbit anti-SOX9 (Millipore 1:300), goat anti-EPHB3 (R&D 1:300),
rabbit anti-GFP (Abcam 1:3000), goat anti-Cryptdin1 (Andre Ouellette), rabbit anti-DVL2
(Cell Signaling 1:100). Antigen retrieval was performed using low pH citrate buffer.
Staining for β-Catenin was performed as previously described35. Lysozyme staining was
performed as follows (Dako Rabbit anti-Human Lysozyme). Antigen retrieval was
performed by proteinase-K digestion at 37 degrees for exactly 12 minutes in tris-EDTA pH
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9 followed by PBS wash for 5 minutes and quenching of endogenous peroxidases and
Vectastain ABC-Elite kit processing. Next, tissue was incubated in primary antibody at
1:1000 in PBS 0.1% Triton at 4 degrees overnight.
In situ hybridization
In situ hybridization for Olfm4 transcripts was performed on formalin fixed intestine at the
specialized histopathology service core at the Dana Farber Cancer Institute using
RNAscope, according to manufacturer’s instructions.
Quantification of H3S10ph and Lysozyme foci
For Villin-CreER experiments, lysozyme quantification was performed on a cohort of five
control (Apc fl/fl) and 5 double cKO (Yap1 fl/fl Apc fl/fl) mice. The quantification was
performed blind to specimen identity. Paneth cell numbers were quantified by the number of
crypt cells staining positive for lysozyme on a per-crypt basis. For each sample, per-crypt
numbers of Lysozyme positive cells were averaged over at least fifteen 10× fields of view
per mouse. In Villin-CreSt experiments, H3S10ph and Lysozyme positivity was counted in a
similar manner. Student’s t-test was used to determine statistical significance with a cutoff
of P<0.05.
DSS treatment
Mice were given 2.5% DSS in drinking water for 7 days, followed by normal drinking water
for 3 days. Colon tissue was snap frozen and cryosections were stained with hematoxylin to
visualize tissue architecture.
siRNA mediated knockdown
Cells were reverse transfected with 7nM final concentration of indicated siRNA (Ambion
Silencer Select) using Lipofectamine RNAiMax (Invitrogen), according to manufacturer’s
instructions. For expression analysis in DLD1 cells, RNA was extracted 4 days after
transfection. Oligos against human transcripts used were (5′-3′): siAPC Sense:
GGAUCUGUAUCAAGCCGUUtt, Antisense: AACGGCUUGAUACAGAUCCtt (ol i g o #
s1433), siYAP Sense: GGUGAUACUAUCAACCAAAtt, Antisense:
UUUGGUUGAUGUAUCACCtg (oligo # s20366), siDVL3 Sense:
GAUAUGUUGUUACAGGUAAtt, Antisense: UUACCUGUAACAACAUAUCtc (oligo #
s675), siDVL2 (pooled 2 siRNAs) Sense: CACCAUCCCUAAUGCCUUUtt, Antisense:
AAAGGCAUUAGGGAUGGUGat (oligo # s4396) and Sense:
CAGUCACGCUAAACAUGGAtt, Antisense: UCCAUGUUUAGCGUGACUGtg (Oligo #
s4398).
RNA extraction, cDNA synthesis and quantitative PCR
RNA was extracted from cells or tissue using RNeasy mini kit according to manufacturer’s
instructions (Qiagen). cDNA synthesis was performed on 1ug of total RNA using iScript
cDNA synthesis kit (Biorad). QPCR was performed using Taqman probes available from
Applied Biosystems and Taqman Fast-Advanced master mix. Probed used were as follows:
mouse Cd44 Mm01277163_m1, Lgr5 Mm00438890_m1, Myc Mm004877804, Wwtr1
(Taz) Mm00513560_m1, Nkd1 Mm00471902_m1, Yap Mm00494240_m1, Sox9
Mm00448840_m1, Cd133 (Prom1) Mm00477115_m1, Axin2 Mm00443610_m1, Apc
Mm00545877_m1 and Fabp2 Mm00433188_m1. Human probes were: NKD1
Hs00263894_m1 and FOXN1 Hs00263894_m1. All reactions were run on Applied
Biosystems Step-One-Plus real-time PCR instrument and data were calculated using the
delta-delta Ct method. Significance values were calculated using Student’s t-Test with a P
value cutoff of less than 0.05.
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Immunofluorescence
For immunocytochemistry of adherent DLD1 cells, cultures were grown on sterile
coverslips and washed once with PBS followed by fixation in 4% paraformaldehyde/PBS
for 15 minutes at room temperature. Cells were then washed twice with cold PBS and
permeabilized with PBS/0.25% Triton X-100 for 10 minutes at room temperature. Cells
were then washed three times in PBS followed by blocking in 1% BSA/PBS for 30 minutes
at room temperature. Next, cells were incubated in primary antibodies in 1% BSA/PBS
overnight at 4 degrees followed by 3 washes in PBS. Cells were then incubated for 1 hour in
dark humidified chamber with Alexa-fluor conjugated secondary antibodies in 1% BSA/
PBS followed by 3 washes in PBS. Coverslips were then stained with DAPI and mounted on
glass slides. Staining was performed with the following antibodies: Mouse anti-YAP (Santa
Cruz 1:500) and rabbit anti-DVL2 (Millipore 1:200).
Co-immunoprecipitation
293T cells were transiently transfected with GFP (negative control) or indicated flag-tagged
versions of YAP2 (Plasmids purchased from Addgene, originally constructed in the lab of
Marius Sudol) or myc-tagged DVL2 (from the Xi He lab) using Lipofectamine 2000. After
48 hours, cells were lysed in buffer containing 1% Triton X-100, 50mM Tris HCl pH 7.4,
150mM NaCl and 1mM EDTA followed by passage through 26 gauge needle 10 times.
Lysates were precleared with protein-A agarose and then incubated in anti-Flag resin (Sigma
Aldrich) for 1 hour 30 minutes while shaking. Protein complexes were then washed 4 times
in lysis buffer and boiled for western detection. Mouse anti-Flag M2 antibody (Sigma
Aldrich) was used at 1:1000 to detect flag-tagged YAP and rabbit anti-Myc antibody (Sigma
Aldrich 1:1000) was used to detect myc-tagged DVL2.
Subcellular fractionation
DLD1 cells were reverse transfected with indicated siRNA. After 4 days, cells were washed
with PBS, scraped and centrifuged. Cells were then resuspended in 3-4 pellet volumes of
fractionation buffer containing sucrose, HEPES, KCl, MgCl, EDTA, NP-40, protease and
phosphatase inhibitors. Cells were then passed through a 25 ½ gauge needle 10 times and
left on ice for 20 minutes and then centrifuged to pellet nuclei away from cytoplasm. Nuclei
were then washed by passage through 25 ½ gauge needle 10 times and centrifuged. Nuclear
and cytoplasmic fractions were then resuspended in equal volumes of lysis buffer and
analyzed by Western blots. The following antibodies were used: mouse anti-YAP (Santa
Cruz 1:1000), rabbit anti-DVL2 (Cell Signaling 1:1000), anti-Fibrillarin (Abcam 1:1000),
anti-Beta Tubulin (Cell Signaling 1:1000).
Wnt reporter assays
293T cells were first transfected with the indicated siRNA. Two days later, TOPflash and
Renilla plasmids were cotransfected. Wnt activity was assayed 48 hours after reporter
transfection. All values are represented as the ratio of firefly to renilla. Transfections were
performed in triplicate.
A stable 293T cell line was used in BIO and Wnt3A + RSpo1 induction experiments. This
line was created by co-transfecting the TOPflash plasmid with a renilla expressing plasmid
(10:1 ratio of firefly to renilla) carrying a blasticidin resistance selection marker. Cells were
selected under 6ug/ml. Clones were picked, expanded and screened for TOPflash activity
after treatment with recombinant Wnt3A. YAP and scrambled siRNAs were transfected at
7nM, and induced with Wnt3A and Wnt3A (500ng/ml) +RSpondin1 (500ng/ml) 3 days later
when cells were approximately 50% confluent, for 16hrs. Induction with bromoindirubin
(5uM) (BIO Sigma Aldrich) was performed in the same manner as with Wnt3A and RSpo1.
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Controls were treated with DMSO. To test the effect of nuclear localized DVL in 293T
WNT reporter assays, a DVL-NLS expressing construct 25 was transiently transfected with
renilla and TOPflash plasmids 3 days after siRNA treatment. Luciferase levels were
measured 48 hours later.
Microarray Analysis
In Tg experiments, whole RNA was extracted from mouse crypts. RNA was extracted from
whole epithelium in RSpo1 experiments. Microarray experiments were performed by the
Microarray Core of the Molecular Genetics Core Facility at Children’s Hospital Boston.
Material was processed for Affymetrix Mouse GeneChip 1.0ST arrays. For each
experimental condition, 3 mice were used. CEL files were converted to GCT files using
ExpressionFileCreator in Gene Pattern, publicly available from the Broad Institute
(genepattern.broadinstitute.org). GCT files were preprocessed and used in the Comparative
Marker Selection module to obtain lists of differentially regulated genes. In Tg experiments,
a threshold of p<=0.05 and fold change of 1.4 or greater was used. In RSpo1 experiments,
fold change of 2 and q-value (FDR corrected p-value) of 0.05 were used as cutoffs.
Expression analysis of human xenograft tumors was performed using Affymetrix Human
GeneChip 1.0ST chips and processed as above. GCT files were used in Comparative Marker
Selection. RNA was used from 3 control (no dox) and 3 YAP-S127D dox induced tumors.
Threshold cutoffs were p<=0.05 and fold change of 1.4-fold or greater. Gene Set
Enrichment Analysis was performed using GCT files from Yap experiments compared to
gene sets cited in the main text.
Organoid culture and lentiviral infection
Organoids were derived, propagated and infected according to previously published
work 36-37. pINDUCER2038 was used for inducible lentiviral expression studies in DLD1
xenografts and organoids.
Human colorectal cancer clinical sample analysis Study population
The databases of two nationwide prospective cohort studies were utilized: the Nurses’
Health Study (N=121,701 women followed since 1976) and the Health Professionals
Follow-up Study (N=51,529 men followed since 1986) 28. We collected paraffin-embedded
tissue blocks from hospitals throughout the U.S. where patients underwent colorectal cancer
resections. Hematoxylin and eosin stained tissue sections from all colorectal cancer cases
were reviewed by a pathologist (S.O.) unaware of other data. Tumor grade was categorized
as low vs. high (>50% vs. ≤50% gland formation). We excluded cases which were
preoperatively treated. Patients were observed until death or January 1, 2011, whichever
came first. Death of a participant was confirmed by the National Death Index. Returning
questionnaire indicated informed consent from all study participants. This study was
approved by the Human Subjects Committees at Harvard School of Public Health and
Brigham and Women’s Hospital.
Immunohistochemistry on human samples
Tissue microarrays were constructed as previously described 39. For YAP
immunohistochemistry, deparaffinized tissue sections were treated with Antigen Retrieval
Citra Solution (Biogenex Laboratories, San Ramon, CA) in microwave for 15 min. Tissue
sections were then incubated with Peroxidase Blocking Reagent (15 min; DAKO) and
primary antibody against YAP (rabbit polyclonal, 1:400 dilution; Cell Signaling) was
applied, and slides were incubated for 16 h at 4 degrees. Next, we applied SignalStain®
Boost IHC Detection Reagent (Cell Signaling) for 30 min followed by visualizing signal
with d i a m i n o b e n z i d i n e ( 5 m i n ; D A K O ) a n d h e m a t o x y l i n c o u n t e r s
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t a i n . E a c h immunohistochemical maker was evaluated by a pathologist (T.M.) unaware
of other data.
Statistical analysis
All statistical analyses were performed by SAS program (Version 9.1, SAS Institute, Cary,
NC). All p values were two-sided and statistical significance was set at p=0.05. For
categorical data, the chi-square test was performed. Kaplan-Meier method and log-rank test
were used for survival analyses.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. YAP overabundance inhibits Wnt-mediated intestinal regeneration
a, H&E staining of doxycycline induced YAP-S127A small intestine at 2, 4 and 7 days.
Inset of Ki67 stain representative of crypt proliferation. b, c, Wnt pathway activity and ISC
presence at 2, 4 and 7 days post dox induction represented by CD44 (b) and Olfm4 (in-situ)
(c). d, Heatmap of crypts isolated from control (n=3) and day 2 dox (n=3) treated mice
displaying 540 downregulated genes in rank order. Labeled genes are examples known to be
involved in Wnt signaling and the ISC niche. Original magnifications in each panel are 20x
(a, b), 10x (c).
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Figure 2. Loss of YAP leads to hyperactive Wnt signaling and expansion of the stem cell niche
after injury or stimulation with RSpo1
a, H&E, CD44, SOX9 and Lysozyme staining of small intestinal crypts in control and cKO
mice 1 week after irradiation. b, H&E of inert virus treated control and cKO small intestine.
c, d, H&E staining (c) and CD44 IHC (d) in control and cKO mice 1 week after
administration of adenovirus expressing RSpo1. e, GSEA of the ISC gene signature and
intestine-specific β-catenin target gene sets. Black bars represent individual genes in rank
order. f, Q-PCR validating several upregulated Wnt/ISC markers. g, h, IHC on small
intestine of control and cKO small intestine for EGFP (expressed from the Lgr5 locus, inset
is an untreated mouse) (g) and Lysozyme marking Paneth cells (h). i, Ectopic crypt
formation in cKO mice treated with RSpo1 stained for H&E or the Wnt target CD44.
Original magnifications in each panel are 20x (a), 10x (b-d), 20x (g) and 10x (h, i). Graphed
data represent the mean and S.E.M. of 3 individual mice per genotype.
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Figure 3. YAP restricts Wnt signaling by blocking DVL nuclear translocation
a, b, DVL2 IHC in control and cKO small intestine treated with Ad-Fc (a) and Ad-RSpo1-
Fc (b). Insets are higher magnifications showing subcellular localization of DVL2. c,
Immunofluorescent staining for DVL2 in confluent DLD1 cells after transfection with
indicated siRNA. d, Expression analysis of Wnt target genes in DLD1 cells after
transfection with siRNAs against YAP, DVL2+DVL3 (D2/3) or YAP + D2/3. e, Expression
analysis of organoids infected with lentivirus encoding Dox-inducible DVL-NLS alone, or
in a Villin-rtTA TetO-YAP-S127A background. Dox was given in culture medium for 4
days. All graphed data represent the mean and standard deviation of triplicate cultures.
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Figure 4. YAP function in human colorectal cancer
a, Xenograft tumor formation of DLD1 cells infected with lentivirus encoding Dox-
inducible YAP-WT or YAP-S127D mutant. Tumor photos are representative images. b,
Heatmap representing the top 328 genes downregulated by YAP-S127D induction in
xenograft assays (n=3 tumors per treatment group). Labeled genes are known β-catenin
targets in human CRC. c, GSEA of TCF4-dependent CRC target genes. d, Overall survival
analysis of patients with specific YAP staining patterns. YAP IHC was placed into 4 groups
of staining patterns correlating with subcellular localization from 672 colorectal cancer
patients: Cytoplasmic and nuclear (C (+) N (+)), Cytoplasmic (C (+) N (−)), Nuclear
positive (C (−) N (+)) and Complete loss of staining (C (−) N (−)). e, YAP staining in low
and high grade tumors. f, YAP loss is significantly associated with high grade tumors and
stage IV disease (CI, confidence interval).
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